Gabby Lehigh public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
Curious to Serious

Psychedelic Grad

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
We interview students & professionals in the psychedelic space to better understand how they navigated the path from being curious about psychedelics to wanting to dedicate their career to psychedelics. Join the community at psychedelicgrad.com.
  continue reading
 
Artwork

1
Altered States of Context

Nathan Gates & Brian Pilecki

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Brian Pilecki and Nathan Gates, two therapists and long-time psychedelic advocates explore the uneasy fit between a medicalized view of individual mental illness and a psychedelic view of suffering and change. We'll also explore many of the possibilities, opportunities and pitfalls that emerge from this union. In addition, we'll keep it weird, and talk about some of the aspects of psychedelic experiencing that make it so interesting, fun, and transformative. This will hold interests for anyo ...
  continue reading
 
Loading …
show series
 
A bit of an ASOC origin story! In this Episode Nate interviews the Perspectives Retreats crew, which include our very own Brian Pilecki, Jenna LeJeune, Miranda Morris and Temple Morris. The idea for Perspectives Retreats originated in the same place as Altered States of Context- at a psilocybin retreat in Jamaica 6 years ago. Since then the Perspec…
  continue reading
 
Dr. Alex Belser joins us to further discuss EMBARK and how his passion for training psychedelic therapists led to the development of a broadly applicable model that includes all aspects of psychedelic experiences. With the recent rejection of MDMA-assisted therapy by the FDA, we discuss the future role of psychotherapy, in contrast to more minimal …
  continue reading
 
Humans are natural storytellers, for better or worse. How can we become more aware of the stories that embed our lives? How do psychedelics help us see the stories that we live inside and help us have more agency about being an author to our stories? Our guest Jennifer Beman is a documentary film editor who has created a method for visual story-tel…
  continue reading
 
Dr. William Brennan describes EMBARK, a transdiagnostic flexible model of psychedelic facilitation that builds on existing approaches in clinical research of psychedelic-assisted therapy. He describes the six clinical domains and four care cornerstones, and how they can be flexibly applied to a range of conditions and settings. We discuss some of t…
  continue reading
 
Gabby Lehigh recently earned her PhD from the Department of Anthropology at the University of South Florida (USF). She holds a bachelor’s degree from Indiana University of Pennsylvania and a master’s degree in anthropology from USF. Her dissertation research focused on transformative psychedelic experiences at music events to understand how psyched…
  continue reading
 
New EPISODES After a bit of a break, we are back with three new episodes and a new format. Instead of biweekly episodes during a season, we are simply going to release episodes whenever we feel like it! We are hoping that this intermittent schedule of reinforcement works well for all of our loyal listeners, as it makes it much easier for us to keep…
  continue reading
 
In this episode, I talk with Gina Gratza, who specializes in psychedelic-assisted facilitation. In our conversation, Gina tells us about the many different organizations she is involved in and the work she does with them, including psychedelic integration and coaching, being an Oregon Psilocybin Facilitator, working with the Social Neuroscience and…
  continue reading
 
In this episode, I talk with Jonathan Robinson, the author of 14 books and a marriage and family therapist located in California. In our conversation, Jonathan tells us about his work in bringing together MDMA experiences and therapy. He discusses how his protocol is unique to other work being done with psychedelic-assisted psychotherapy by emphasi…
  continue reading
 
Andy Mitchell, author of “Ten Trips,” describes his experience having ten different psychedelic experiences in very different types of contexts ranging from academic settings to indigenous communities. Andy provides a fresh take on psychedelics with a unique perspective of sampling several sub-communities within the larger psychedelic community, in…
  continue reading
 
In this episode, I talk with Christi Meyers, the Founder and CEO of Flow Integrative, a ketamine infusion clinic in San Diego, California. In our conversation, Christi tells us about Flow Integrative as a form of practicing medicine that provides ketamine infusion therapy, as well as Flow Institute as an educational platform. She discusses the char…
  continue reading
 
In this episode we take a slight detour from our main topic to discuss Nate’s experiences with farming in central Illinois. Hear Nate describe how he got into farming and how his experiences with animals have shaped the way he thinks about everything from diet to psychotherapy. You’ll hear Nate defend why he is virulently "pro-savanna" and discuss …
  continue reading
 
Join us for a conversation with Franklin King, is a psychiatrist with expertise in neuroscience and psychedelics. Hear him discuss his history of working in a psych ER and his perspectives on how public health interventions can help people attain greater wellness. Dr. King’s unique experience in mental health care and research on psychedelic-assist…
  continue reading
 
In this episode, I talk with Dr. Howard Lipp and Ena Vie. Dr. Howard Lipp and Ena Vie have been working as underground facilitators of plant medicine for several years. In our conversation, they speak about how they were called to plant medicine and found each other through music. We also talk about opening up about facilitating plant medicine cere…
  continue reading
 
In this episode, I talk with Mariya Punay. Mariya is working towards becoming a licensed psychotherapist in California. In our conversation, Mariya speaks to the meticulous process of working on becoming licensed by the Board of Behavioral Sciences (BBS) and the many challenges she's faced throughout the process. She also speaks to the essential ne…
  continue reading
 
Holotropic breathwork, developed by Stan and Christina Grof, [BP1] was developed as a method to induce altered states of consciousness after LSD was made illegal and therefore no longer available. Christine Calvert is a certified Holotropic Breathwork facilitator who discusses the history and development of holotropic breathwork and how it is relat…
  continue reading
 
In this episode, I talk with Gina Giorgio. Gina wears many hats within the psychedelic space as founder of the North Carolina Psychedelic Policy Coalition, the Director of the Students for Sensible Drug Policy (SSDP) Mentorship Pipeline, a Communications and Policy Specialist for NisonCo, a contributing writer for Psychedelic Spotlight, and the Fou…
  continue reading
 
In this compelling episode, Nate and Brian are joined by Victor Cabral, a licensed social worker and therapist, who currently serves as the Director of Policy and Regulatory Affairs at Fluence Training. Victor has a passion for equity and justice in relation to drug policies and hopes to emphasize community views, oppression, and harm that has been…
  continue reading
 
In this episode, I talk with Sapha. He is a practicing Cuarandero and a Recovery Consultant at Sacred Rebels Recovery, a peer-led addiction recovery program for men housed at the Nihue Rao Spiritual Center in the Peruvian Amazon. In our conversation, Sapha highlights the uniqueness of Sacred Rebels in providing alternative recovery options for peop…
  continue reading
 
OSMIND Osmind is the premier platform for psychedelic-assisted psychotherapy practices. The all-in-one platform includes purpose-built charting for ketamine, SPRAVATO, psychotherapy and more; as well as patient tools for the therapeutic alliance that include 40+ validated rating scales and a patient app for journaling and secure messaging too. Visi…
  continue reading
 
Show Description: In this fascinating episode, Brian is joined by Denise Rue, who is a hypnotherapist, social worker, and experienced psilocybin retreat facilitator. Brian and Denise dive deep into the nature of psychedelic therapy and the retreat experience, from preparation through integration. Denise shares her perspective on the role of a psych…
  continue reading
 
OSMIND Osmind is the premier platform for psychedelic-assisted psychotherapy practices. The all-in-one platform includes purpose-built charting for ketamine, SPRAVATO, psychotherapy and more; as well as patient tools for the therapeutic alliance that include 40+ validated rating scales and a patient app for journaling and secure messaging too. Visi…
  continue reading
 
This Episode's Sponsor OSMIND Osmind is the premier platform for psychedelic-assisted psychotherapy practices. The all-in-one platform includes purpose-built charting for ketamine, SPRAVATO, psychotherapy and more; as well as patient tools for the therapeutic alliance that include 40+ validated rating scales and a patient app for journaling and sec…
  continue reading
 
This episode is the second in our occasional “About Us” series, where we feature members of the Psychedelic Grad team. In this episode, Gabby sits down with Andrew Mcmillian, the Community Meetings Organizer at Psychedelic Grad. We talk about Andrew’s experiences in research labs at the University of South Florida (USF) while earning his Bachelor’s…
  continue reading
 
In this episode, I talk with Hadas Alterman. She is the Director of Government Affairs at the American Psychedelic Practitioners Association (APPA), which is working to build accessibility in clinical psychedelic therapy by establishing standards for training therapists to do this work. In our conversations, we talk about Hadas’ work with the Psych…
  continue reading
 
This episode is the first in our occasional “About Us” series, where we feature members of the Psychedelic Grad team. In this episode, Emma talks with me, Gabby Lehigh, Psychedelic Grad Co-founder and Curious to Serious co-host. We talk about my recent achievement of successfully defending my doctoral dissertation and getting my Ph.D. in Anthropolo…
  continue reading
 
In this episode, I talk with Sam Banister. He is the co-founder and Chief Scientific Officer at Psylo, a biotech company in Australia that develops different classes of pharmaceutical psychedelics to help treat patients with serious mental health disorders. In our conversation, we talk about Sam’s journey into psychedelics by learning about Albert …
  continue reading
 
In this episode, we talk with Kaitlin Robertson. She is the CEO of Cacti Therapeutics, a biotech company developing FDA-approved psychedelic therapies for chronic pain and sexual dysfunction. Kaitlin received her Master’s degree in Human Development and Psychology from Harvard University and has professional experience in trauma care and business f…
  continue reading
 
In this episode, I talk with Sa’ed Al-Olimat. He is the founder of PsiloHealth, co-founder and Board Director of the Psychedelic Pharmacists Association, and a community pharmacy manager at CVS. In our conversation, we talk about Sa’ed’s many roles in the psychedelic space, including founding Psilohealth, an organization dedicated to education, leg…
  continue reading
 
In this episode, I talk with Heather Wickman. She is the co-founder of Untethered with her husband, Colby. They offer unique integration services with horses and partner with organizations worldwide to offer plant medicine experiences for individual growth initiatives. In our conversation, we talk about Heather’s work in the corporate world as an e…
  continue reading
 
Dr. Rosalind Watts discusses her work in applying Acceptance and Commitment Therapy to psychedelic-assisted therapy. Dr. Watts shares about how her own challenging psychedelic experiences have provided her with valuable insight and perspective in working with depressed clients, as well as the value in opening up to our pain in helping us become mor…
  continue reading
 
In this episode, we talk with Steven Millar. He is a recent master’s graduate from Glasgow University and an aspiring psychedelic-assisted therapist. In our conversation, we talk about Steven’s academic experiences at Glasgow University, studying Philosophy and Spanish during his undergraduate and Psychology for his master’s degree. We also discuss…
  continue reading
 
Zach Haigney is the author of the Trip Report, a weekly newsletter that synthesizes psychedelic news in the areas of medicine, science, and policy. Looking at the big picture, we discuss where the field is at and where it is going. We review the hype cycle and identify why psychedelics tend to be aggrandized, and Zach discusses his view of how the …
  continue reading
 
In this episode, we talk with Daniel Tarockoff. He is a partner at Vine Ventures; an early-stage venture fund focused on psychedelics. In our conversation, we examine Daniel’s work at Vine Ventures. We also talk about venture capital funds, Vine Ventures' reciprocity pledge, and their fundraising efforts for MAPS. We also cover Daniel’s journey fro…
  continue reading
 
Dr. Ingmar Gorman discusses the current state of psychedelic training programs and how Fluence, the organization that he helped co-found, is attempting to meet the training needs of mental health professionals. He also discusses the little known history of psychedelics in the Czech Republic and Europe, and describes what it was like for psychedelic…
  continue reading
 
In this episode, we talk with Ryan “Ghenigho” Rich. He is the Founder and Ceremony and Detox Lead at Root Healing Iboga Retreats and Detox. In our conversation, we explore Ryan’s work at Root Healing. We talk about how Root Healing is unique by centering their Iboga retreats in Bwiti tradition while also exploring the scientific efficacy of Iboga. …
  continue reading
 
Psychedelics are known for their ability to shake up one’s existing belief system and provoke new ways of seeing the world. Several studies show that people often become more spiritual or religious after a powerful psychedelic experience. There is a trend in moving away from physical or materialistic worldviews into non-physical, fatalistic, or non…
  continue reading
 
Dr. Rachel Harris shares her work in investigating the ceremonial use of ayahuasca and how understanding indigenous cultures can help inform the Westernized medical framework of psychedelic-assisted therapy. Dr. Harris also discusses her upcoming book about the work of female underground guides and elders, and why the voices of women have been larg…
  continue reading
 
Much of the current discussion around psychedelic drugs center on their therapeutic effects. Clinical conversations, promotion, hype, controversy- who controls them, who are they good for, how can they be used for maximum benefit, who's getting paid... A little something has gotten a bit lost in the mix- FUN. Psychedelics can be a real, real good t…
  continue reading
 
Dr. Chris Stauffer talks about his research investigating the use of group-administered psilocybin and MDMA. The advantages of group administration are discussed, including the opportunity to increase social connection and deepen capacities to be vulnerable with others. Dr. Stauffer also highlights how group psychedelic-assisted therapy needs to be…
  continue reading
 
In this episode, we talk to Christine Ziemer. Dr. Christine Ziemer is a professor of psychology at Missouri Western State University, faculty advisor of the SSDP Chapter, and excellent harm reductionist. Christine became interested in psychedelics and MAPS during her time in graduate school while working for her Ph.D. in psychology. Since then it h…
  continue reading
 
In this edition of ASOC, we had the opportunity for a long, in-depth conversation with the one and only Dr. Steven C. Hayes. In this fun and wide-ranging conversation, Steve talks about how his personal experiences with psychedelics contributed to the development of Acceptance and Commitment Therapy and his understanding of the role of language in …
  continue reading
 
Should psychedelic therapists have their own experiences with psychedelics? While the answer to this question may at first seem obvious, this episode explores some of the nuances in this issue. For example, if personal experience is necessary, who gets to decide how much and under what conditions? Furthermore, we explore how personal experiences ma…
  continue reading
 
In this episode, Nate interviews Dr. Albert Garcia Romeu of Johns Hopkins Center for Psychedelic and Consciousness Research. First, we discuss the state of diversity within psychedelic research, both in terms of the research subjects and the researchers themselves. We pointed out how this may be particularly problematic in psychedelic science, as i…
  continue reading
 
What are bad trips and why do they happen? What are the different ways that things can go wrong? In this episode we explore various sub-types of psychedelic experiences and debate the differences between challenging trips and bad trips, and how difficult experiences can often lead to healing and growth with the right support. We dismantle the idea …
  continue reading
 
ACT has already been used to inform the psychotherapy portions of psilocybin-assisted therapy in several clinical trials. Dr. Jordan Sloshower shares about his experiences working on a clinical trial of psilocybin-assisted therapy for depression. He discusses why his team chose ACT from among several potential therapy models, as well as his views o…
  continue reading
 
In this episode, we talk to Max C Wood. Max is a graduate student studying developmental neuroscience and psychopathology. Max spent last year studying at the Anna Freud Center in London, and is now currently at Yale - researching into the impact attachment styles have on a psychedelic treatment design. Broadly speaking, his passions lie in the int…
  continue reading
 
Season two begins with a summary of recent news in psychedelics, including developments in decriminalization efforts by several states, an update on Oregon’s measure 109 and psilocybin services, and the recent dissolving of Mindcure and what that means for big money players in the psychedelic space. Nate and Brian also speculate on various potentia…
  continue reading
 
In this episode, we talk with David Drapkin. He is the Director of Operations and Strategic Growth at Psychedelics Today. In our conversation, we explore David’s work at Psychedelics Today, including his role in creating Psychedelic Today’s newest course, Vital. We discuss David’s history in economics and how a near-death experience changed his pat…
  continue reading
 
We're Back! Well, not quite. We are releasing this FULL EPISODE now because it's timely, and because we ARE coming back, and soon! New episodes will be coming back at you every other week starting at the end of March. We've been hard at work and have numerous interviews recorded and queued up for the editing bay. We're very excited to share them wi…
  continue reading
 
Loading …

Quick Reference Guide

Listen to this show while you explore
Play